cro.directory
Home
Noble Life Sciences logo

Noble Life Sciences

Preclinical CRO accelerating drug and device development from discovery through IND-enabling studies.

Advanced preclinical CRO providing comprehensive drug and device development services including bioanalysis, GLP toxicology, pharmacodynamic modeling, and specialized testing for oncology, infectious disease, gene therapy, and synthetic biology programs.

Phases

Indications / Therapeutic Areas

Services

Modalities

Technical specifications & accreditations

Accreditations

About this organization

Noble Life Sciences is a preclinical contract research organization supporting drug, biologic, cell and gene therapy, and medical device programs across the full preclinical lifecycle. Services span early discovery through IND-enabling and GLP toxicology studies designed to meet regulatory expectations.

Service Capabilities

  • Preclinical Testing: Contract research and development, GLP-compliant safety testing, pharmacodynamic modeling, and analytical testing
  • Bioanalysis: Comprehensive bioanalytical services supporting drug development
  • Therapeutic Expertise: Specialized preclinical models and services for oncology (including immuno-oncology), infectious diseases (including SARS-CoV-2 research), gene therapy (AAV), cell therapy, and synthetic biology
  • Advanced Models: In vivo and in vitro preclinical models, OncoDiversity Cell Line Panel, and translational development support for small molecules and biologics

Client Base

Works with biotech and pharmaceutical companies including DEKA BioSciences, RegenXBio (AAV gene therapy), Jaguar Gene Therapy, Amicrobe (synthetic biologics), and Britecyte (regenerative medicine).

Similar profiles by shared services, phases, and indications.

Submit a verified review for this organization.

Markdown mirror: /companies/noblelifesci.md